Treatment of heparin-induced thrombocytopenia and thrombosis.
Green
R M
RM
Section of Vascular Surgery, University of Rochester Medical Center, NY 14642, USA.
D000721:Ancrod / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D006493:Heparin / Q000009:adverse effects*; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects; D006801:Humans; D015539:Platelet Activation / Q000502:physiology; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin; D000721:Ancrod